Quantum Genomics Secures €3 Million Non-dilutive Financing
April 28, 2021 12:04 ET
|
Quantum Genomics
€1.5 million guaranteed by the French government (PGE) and granted by BNP bank €1.5 million innovation and R&D loan granted by Bpifrance Funding will allow for acceleration of R&D programs ...
Quantum Genomics Will Present Top-line Results From its QUORUM Study of Firibastat in Heart Failure Post Myocardial Infarction at the European Society of Cardiology (ESC) Meeting
April 21, 2021 02:00 ET
|
Quantum Genomics
PARIS, April 21, 2021 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the...
Quantum Genomics Announces the End of its Collaboration with Qilu for the Development and Commercialization of Firibastat in China
April 20, 2021 02:00 ET
|
Quantum Genomics
PARIS and NEW YORK, April 20, 2021 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in developing a new drug class that...
Quantum Genomics Reports Full Year 2020 Operating and Financial Results
March 25, 2021 13:00 ET
|
Quantum Genomics
Recruitment of first subjects for Phase III trial in difficult-to-treat and resistant arterial hypertension patients Finalization of recruitment for Phase IIb trial in heart failure with upcoming...
Orient EuroPharma Acquires Equity Stake in Quantum Genomics
February 09, 2021 12:00 ET
|
Quantum Genomics
PARIS and NEW YORK, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of a new class of drugs...
Quantum Genomics Launches Phase III Pivotal REFRESH Study in Difficult-to-treat/Resistant Hypertension with Once-a-day Formulation of Firibastat
January 18, 2021 15:30 ET
|
Quantum Genomics
PARIS and NEW YORK, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly...
Quantum Genomics Signs a Strategic Contract with Delpharm
December 16, 2020 02:00 ET
|
Quantum Genomics
PARIS and NEW YORK, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of a new class of drugs...
Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Faran
December 15, 2020 02:00 ET
|
Quantum Genomics
Quantum Genomics to receive up to $12.1 million in upfront and milestone payments plus double-digit royalties on sales Faran to receive an exclusive license to develop and commercialize firibastat...
Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with DongWha Pharm
December 02, 2020 11:50 ET
|
Quantum Genomics
Quantum Genomics to receive up to $18.5 million in upfront and milestone payments plus double-digit royalties on sales DongWha Pharm to receive an exclusive license to develop and commercialize...
Quantum Genomics Announces End of Financing Agreement with Negma Group Ltd/Park Partners
November 02, 2020 12:00 ET
|
Quantum Genomics
PARIS and NEW YORK, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly...